Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors.
published in: Biochimica et Biophysica Acta
date of publication: 2018-01-31
Cites articles 1
- 2002-06-27
Date
Title
Article - wd:Q50136878
Article - wd:Q50136878